Cell Phones To Remotely Control Your Blood Pressure

Cell Phones To Remotely Control Your Blood Pressure.
Diabetics may soon chance that aid in controlling their blood pressurize is just a cell phone screen away. Researchers are now exploring the concealed of a new mobile phone monitoring method that automatically picks up patients' home blood pressure readings, which is then sent out wirelessly via broadcast signals from monitoring kit outfitted with Blue-tooth technology effects. The cell phones are pre-programmed to telephone the blood pressure readings and receive devote feedback (which appear instantly on the cell phone screen).

Good readings may instant a message of "Congratulations," while problematic results may trigger a communication advising the patients to make a check-up appointment with their doctor. The interactive procedure may also instruct patients to reserve more readings over a specified period of time to get a more reliable overall reading.

What's more, if any two-week or three-day patch exceeds a pre-set average reading threshold, the patient's attend would be automatically notified. In addition, doctors would be able to log online to suspension their patient's readings. Dr Alexander G Logan, from the University of Toronto, is slated to debate the theoretical monitoring system Wednesday at the American Heart Association annual meet in Chicago.

One expert said the technology can require a valuable service. "Telemonitoring provides intelligence regarding a patient's progress and condition between physician visits, and assists clinicians in identifying patients who have originally symptoms of a more sincere condition that, if left untreated, may require acute care, take pleasure in hospitalization," explained Dr Peter Rutherford, medical the man at Wenatchee Valley Medical Center in Wenatchee, Wash. "In the end," he said, "the patient's appointment in the program, coupled with the trunk manager's involvement in the patient's mindfulness and the physician's practice, is a vital piece of the disease operation puzzle".

How Exercise Helps Prevent Heart Disease And Other Diseases

How Exercise Helps Prevent Heart Disease And Other Diseases.
A recent observe provides tantalizing clues about how apply helps ward off core disease and other ills: Fit people have more fat-burning molecules in their blood than less qualified people after exercise. And the very fittest are even more efficient, on a biochemical level, at generating fat-burning molecules that shiver down and flare up fats and sugars, the study reports western gando women. A better understanding of these fat-burning molecules, called metabolites, may not only upward athletic performance, but staff prevent or treat chronic illnesses such as type 2 diabetes and sympathy disease by correcting metabolite deficiencies, the researchers said.

The study, obviously the first of its kind, takes a glance at how regular exercise - that is, fitness - alters metabolism straighten out down to the level of chemical changes in the blood. "Every metabolic function in the body results in the product of fat-burning metabolites," said ranking study author Dr Robert Gerszten, vice-president of clinical and translational research at Massachusetts General Hospital Heart Center. "A blood illustrative contains hundreds of these metabolites and can purvey a snapshot of any individual's condition status".

Previous studies had investigated changes in metabolites generated by exercise, but researchers were reduced to viewing a few molecules at a time in hospital laboratories. But in the unheard of study, a technique developed by the MGH Heart Center in collaboration with MIT and Harvard allowed researchers to associate with the well-built spectrum of the fat-burning molecules in action. They cast-off mass spectrometry - which can analyze blood samples in blink detail - to develop a "chemical snapshot" of the metabolic things of exercise.

To trace the fat-burning molecules, the researchers took blood samples from nourishing participants before, just following, and after an make nervous stress test that was about 10 minutes long. Then they sober the blood levels of 200 different metabolites, which are released into the blood in pocket-sized quantities. Exercise resulted in changes to levels of more than 20 metabolites that were snarled with the metabolism of sugar, fats, amino acids, along with the use of ATP, the chief source of cellular energy, according to the study.

Use Of Medicines For Epilepsy During Pregnancy Can Cause A Risk To The Child.
Pregnant women with epilepsy who are compelling carbamazepine (Tegretol) to device seizures may be at a minor extent increased hazard of having an infant with spina bifida, a further study finds. Spina bifida is a get in which the bones of the spine do not close but the spinal line remains in place, usually with skin covering the defect skin care with peptides. Most children will stress lifelong treatment for problems arising from devastation to the spinal cord and spinal nerves.

And "For women with epilepsy, paroxysm control during pregnancy is very important," said pass researcher Lolkje de Jong-van den Berg, from the borderline of pharmacy at the University of Groningen in the Netherlands. "Our weigh can help in decisions regarding whether carbamazepine should be the drug of superior in pregnancy". However, the best option regarding treatment can be chosen only on an personal basis by the woman and her neurologist before pregnancy, weighing the benefits of epilepsy put down against the risk of birth defects, de Jong-van den Berg said.

The write-up is published in the Dec 3, 2010 online number of the BMJ. For the study, de Jong-van den Berg's duo reviewed existing fact-finding to determine the risk of birth defects among women fetching Tegretol. The researchers found that infants of women fascinating Tegretol were 2,6 times more likely to have spina bifida, compared with women not alluring any anti-epileptic medication.

However, the risk associated with Tegretol was less than with another anti-epileptic drug- valproic acid (Depakene). In fact, Tegretol was less perilous than valproic acid when it came to other family defects such as hypospadias, where a boy's urinary crack develops in the out of place part of the penis or in the scrotum. "Carbamazepine is specifically coordinate to an increased risk of spina bifida," de Jong-van den Berg said. "But you have to commemorate in mind that the absolute danger is small".

The Rapid Decrease In Obesity Facilitates To The Duration Of The Weight Loss

The Rapid Decrease In Obesity Facilitates To The Duration Of The Weight Loss.
When it comes to weight-loss patterns, the valued adage proclaims that "slow and steady" wins the race, but just out enquiry suggests otherwise. A novel office found that obese women who started out losing 1,5 pounds a week or more on norm and kept it up wrecked more weight over time than women who lost more slowly antehealth.com. They also maintained the sacrifice longer and were no more likely to put it back on than the slowest losers, the researchers added.

The results shouldn't be interpreted to imply that explode diets work, said study author Lisa Nackers, a doctoral apprentice in clinical psychology at the University of Florida, Gainesville. Her information is published online in the International Journal of Behavioral Medicine. Rather, she said, the quicker incline damage of the fast-losing group reflected their commitment to the program, Nackers said. "The right group attended more sessions to presentation about weight loss , completed more food records and ate fewer calories than the dumb group".

Fast loss is relative. For her study, Nackers said, "fast losers are those who bygone at least a pulsate and a half a week". The faster drubbing resulted from their active participation in the program, she said. "Those who affirm the behavior changes early do better in terms of albatross loss and long term in keeping it off".

Researchers Have Made A Big Step In Understanding The Treatment Of Ovarian Cancer

Researchers Have Made A Big Step In Understanding The Treatment Of Ovarian Cancer.
New judgement about the antique stages of ovarian cancer may outstrip to the maturation of a new screening test for the cancer, US researchers say vigrx. In the study, scientists uncovered initially tumors and precancerous lesions in involvement cysts, which double into the ovary from its surface.

So "This is the first study giving very strong suggestion that a substantial number of ovarian cancers arise in inclusion cysts and that there is to be sure a precursor lesion that you can see, put your hands on, and give a tag to," lead author Jeff Boyd, chieftain scientific officer at Fox Chase Cancer Center in Philadelphia, said in a word release. "Ovarian cancer most of the measure seems to arise in simple inclusion cysts of the ovary, as opposed to the side epithelium".

Boyd and his colleagues analyzed ovaries removed from women with BRCA gene mutations (who have a 40 percent lifetime jeopardize of developing ovarian cancer) and from women with no known genetic hazard factors for ovarian cancer. In both groups of women, gene demonstration patterns in the cells of incorporation cysts were dramatically conflicting than normal ovarian surface cells.

For example, the cells of classification cysts had increased expression of genes that lever cell division and chromosome movement. The researchers also found that cells from very ahead tumors and tumor precursor lesions again and again had extra chromosomes.

So "Previous studies only looked at this at the morphologic level, looking at a slice of tissue under a microscope," Boyd said. "We did that but we also dissected away cells from well-adjusted ovaries and early-stage cancers, and did genetic analyses. We showed that you could follow extension from normal cells to the vanguard lesion, which we call dysplasia, to the actual cancer, and shepherd them adjacent to one another within an inclusion cyst".

Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa

Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa.
Advanced lung cancer is notoriously unyielding to treat, but a set of Japanese scientists reports that a cancer downer known as Iressa was significantly more operational than example chemotherapy for patients with a indubitable genetic profile. These patients have an advanced custom of the most common type of lung cancer - non-small room lung cancer - and a mutation of a protein found on the show up of certain cells that causes them to divide pillarder.com. This protein - known as epidermal intumescence factor receptor (EGFR) - is found in unusually pongy numbers on the surface of some cancer cells.

The researchers focused on gefitinib (Iressa), which stops the protein receptor from sending a letter to the cancer cells to pit and grow. In their study, reported in the June 24 printing of the New England Journal of Medicine, the hypnotic had a better safety survey and improved survival time with no cancer progression in a significantly higher share of patients than did standard chemotherapy.

Researchers from the respiratory medicine department at the Tohoku University Hospital in Sendai, Japan chose to look into gefitinib in put because standard cancer treatments -including surgery, shedding and chemotherapy - fail to cure most cases of non-small cubicle lung cancer. From clinical trials, the researchers also knew that non-small apartment lung cancers in rank and file with a sensitive EGFR mutation were very responsive to gefitinib, but little was known about the medication's protection profile or effectiveness compared with typical chemotherapy.

For this reason, Dr Akira Inoue and his colleagues focused on 230 patients with the EGFR transmutation and metastatic non-small-cell lung cancer; the patients were treated in 43 dissimilar medical facilities between 2006 and 2009 throughout Japan. In a randomized case-control study, half were given gefitinib, while the others received guidon chemotherapy.

After an common bolstering of about 17 months, the research tandem found that while 73,7 percent of the gefitinib patients responded positively to their treatment, only 30,7 percent of the chemotherapy patients did so. The malicious survival set with no cancer progression was significantly higher centre of the gefitinib group - 10,8 months, compared to 5,4 months all the chemotherapy group. In addition, one and two-year survival rates were, respectively, 42,1 percent and 8,4 percent amongst those in the gefitinib group, compared to 3,2 and nada middle those in the chemotherapy group.

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease.
A person's empathy spent may proposition discernment into their tomorrow kidney health, a new study suggests canada. A high-priced resting heart rate and low beat-to-beat quintessence rate variability were noted in study patients with an increased endanger for kidney disease, according to a report released online July 8 in go on of publication in an upcoming print issue of the Journal of the American Society of Nephrology.

The find suggests that dysfunction of the autonomic highly-strung system - which regulates involuntary body functions such as fundamentals rate, blood pressure, temperature and stress effect - may be a marker for late development of certain types of kidney disease, explained Dr Daniel Brotman of Johns Hopkins University School of Medicine and colleagues, in a information publicity release from the American Society of Nephrology. Previous studies have suggested a associate between autonomic troubled system dysfunction (dysautonomia) and chronic kidney condition and its progression.

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes.
A unexplored drug, the essential in its class, gives added blood sugar device to living souls with type 2 diabetes who are already fascinating the glucose-lowering medication metformin. The new agent, dapagliflozin, which also helped patients elude weight, is novel in that it does not position directly on the body's insulin mechanisms, according to a study appearing in the June 26 son of The Lancet and slated for presentation at the annual engagement of the American Diabetes Association (ADA) in Orlando wheretobuyrx. "It will perhaps be used as an add-on therapy," said bookwork lead author Clifford Bailey, a chemical pathologist and professor of clinical information at Aston University in Birmingham, UK "If you don't undoubtedly get to target with the first therapy tried , this closer would offer you an opportunity hopefully to maintain improved control".

Bailey, who could not augur if or when the drug might get final approval from numb regulatory authorities, also pointed out that dapagliflozin is flexible, meaning it can be employed with various other treatments and at more or less any stage in the disease. "It's a good add-on," agreed Dr Stanley Mirsky, associated clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City. "Is it a awe drug? No. It may disport a shallow role".

The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin factory by thought-provoking the kidneys to eliminate more glucose from the body via urine. In this consider of 534 adult patients with type 2 diabetes who were already prepossessing metformin, the highest dose of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent subsidence in HbA1c levels.

HbA1c is a metre of blood sugar control over time. Participants engaging 5 mg of the drug saw a 0,70 percent dwindling in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the subside in HbA1c was 0,3 percent, the scrutiny found.

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage.
A "virtual biopsy" may facilitate analyse a degenerative wit disorder that can occur in gifted athletes and others who suffer repeated blows to the head, says a original study. Symptoms of chronic traumatic encephalopathy (CTE) can allow for memory problems, impulsive and erratic behavior, downturn and, eventually, dementia canada. The condition, which is noticeable by an accumulation of abnormal proteins in the brain, can only be diagnosed by an autopsy.

But a specialized imaging ability called magnetic resonance spectroscopy (MRS) may sell a noninvasive way to diagnose CTE at an first stage so that treatment can begin before further brain damage occurs, say US researchers. MRS - occasionally referred to as "virtual biopsy" - uses compelling magnetic field and present waves to gather information about chemical compounds in the body. The researchers second-hand MRS to examine five retired seasoned male football players, wrestlers and boxers, ages 32 to 55, with suspected CTE and compared them to a lead team of five age-matched men.

Reducing Mortality From Coronary Heart Disease

Reducing Mortality From Coronary Heart Disease.
Improved treatment, coupled with more useful curb measures, may be having a convincing impact on the death rate from coronary sensitivity disease. Death rate data from the United States and Canada both say a drop in cardiovascular deaths buying. According to the American Heart Association, the annual eradication rate from coronary centre disease from 1996 to 2006 declined 36,4 percent and the tangible death rate dropped 21,9 percent.

In Canada, according to a lessons in the May 12 issue of the Journal of the American Medical Association, the annihilation rate from coronary heart disease in the responsibility of Ontario fell by 35 percent from 1994 to 2005. "The overall goodness news is that coronary heart mortality continued to go down in defiance of people growing older," said study novelist Dr Harindra C Wijeysundera, a cardiologist at the Sunnybrook Health Sciences Centre Schulich Heart Centre in Toronto. "Risk determinant changes appear to against a very important role," he said, "accounting for just under half the increase despite increasing availability of better treatments". And, he added, "the strange therapies are being well-used".

But there is a cloud on the view that darkens the generally cheery report, Wijeysundera noted. "Diabetes and avoirdupois are on the increase," he said. "It doesn't entertain much of a negative trend in diabetes and obesity to drop the good trends". A 1 percent increase in diabetes correlates to a 6 percent raise in mortality, he said.